Our primary research objectives include:
Development of iPSC-based disease models: We have generated over 100 induced pluripotent stem cell (iPSC) lines from patients with rare monogenetic…
The HIH warmly congratulates Prof. Martin Giese to the successful next step on the way to the Excellence Initiative 2026. The successful concept “Bionic Intelligence for Health” will be coordinated…
Titel der Studie:
NOA-18 , IMPROVE CODEL; neu diagnostiziertes Gliom mit 1p/19q Codeletion
Phase/Studiendesign:
Phase III (AMG), multizentrisch national
Sponsor der Studie:
…
2. Erste Progression des Glioblastoms
Titel der Studie:
GBM AGILE
Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial…
In a new Nature Medicine publication, Prof. Mathias Jucker, Head of the Department of Cellular Neurology at the HIH, & Prof. Lary C. Walker from the Department of Neurology and the Emory National…
The imprint of the University Hospital Tübingen applies to this website.
Responsible for the website of the Hertie Center of Neurology is:
Prof. Dr. Thomas Gasser…
The imprint of the University Hospital Tübingen applies to this website.
Responsible for the website of the Hertie Center of Neurology is:
Prof. Dr. Thomas Gasser…
Department of Neurology and Interdisciplinary Neuro-Oncology
Hertie Center of Neurology Hertie Institute for Clinical Brain Research Department Neurodegenerative Diseases Prof. Dr. Dr.…
